Management of the website has been transferred from NHMRC to the Commonwealth Department of Health. Disruption to site users as a consequence of this change should be minimal. Users should note that email notifications coming from the website will come from from Friday the 8th of April 2022. Any user experiencing difficulty as a result of this change should direct enquiries to for assistance.

The Good Practice Process for Site Assessment and Authorisation Phases of Clinical Trial Research Governance

The Good Practice Process aims to streamline the site assessment and site authorisation of clinical trials by:

  • Outlining a set of principles and critical success factors for site assessment and site authorisation;
  • Detailing a set of planning and preparation activities that can made a site more responsive to commencing clinical trials; and
  • Proposing a streamlined workflow for site assessment and authorisation.

Adopting the Good Practice Process and employing a Clinical Trial Liaison Officer can reduce the clinical trial start-up timeframe by more than 100 days.Good Practice Process Documents